David Anderson
Company: VBI Vaccines
Job title: Chief Scientific Officer
Seminars:
Chair’s Closing Remarks & End of Conference 4:30 pm
day: Day Two
Chair’s Opening Remarks 8:25 am
day: Day Two
Clinical Trial Design Considerations for a Combination Therapy with Multiple Mechanisms of Action to Achieve a Functional Cure 11:00 am
• What can we learn from existing clinical collaborations and clinical data to inform combination therapy for chronic HBV? • Establishing effective biomarkers to measure efficacy • Constructing multi-arm trials to evaluate different combinationsRead more
day: Day One
Panel Discussion: What, When & How? Pursuing Combination Therapy to Improve Durable Efficacy & Decrease Viral Breakthrough 8:30 am
• Sequencing multiple mechanisms of action acting on immune and viral targets to optimize therapeutic effect • Identifying effective combinations to achieve treatment with finite durations • Measuring toxicity and adverse events in combination therapy for HBVRead more
day: Day One